Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer
Clinical trial NCT02718859 · COMPLETED
Trial details
- NCT number
- NCT02718859
- Sponsor
- Fuda Cancer Hospital, Guangzhou
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2017-03-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.